AN CD47 BINDENDES ANTIGENBINDENDES POLYPEPTID UND VERWENDUNG DAVON
European patent · EP4130042 · In force
Register entry
- Publication number
- EP4130042
- Application number
- EP21780305
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Apr 1, 2021
- Published
- Feb 8, 2023
- Granted
- Feb 18, 2026
- Protection ends at the latest
- Mar 31, 2041
- Next annual fee due
- Apr 30, 2026
- IPC classes
- C07K 16/28 (2006.01)C07K 16/46 (2006.01)C12N 15/13 (2006.01)C12N 15/63 (2006.01)A61K 39/395 (2006.01)A61P 35/00 (2006.01)A61P 35/02 (2006.01)
- Priority
- CN 202010255615 02.04.2020
- PCT application
- PCT/CN2021/084802 01.04.2021
- PCT publication
- WO2021/197401 07.10.2021
- Filing language
- Chinese
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Feb 18, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 18.02.2026
Parties
Inventor
GUI, Qiu
Nanjing, Jiangsu 211100, CN
ZHU, Hong
Nanjing, Jiangsu 211100, CN
WANG, Liangliang
Nanjing, Jiangsu 211100, CN
ZHANG, Xiaoyun
Nanjing, Jiangsu 211100, CN
ZOU, Xiaofang
Nanjing, Jiangsu 211100, CN
SHEN, Hengqiao
Nanjing, Jiangsu 211100, CN
XU, Hongjiang
Nanjing, Jiangsu 211100, CN
YANG, Ling
Nanjing, Jiangsu 211100, CN
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.